Health Care & Life Sciences » Pharmaceuticals | vTv Therapeutics Inc.

vTv Therapeutics Inc.

vTv Therapeutics Inc. Cl A
Stock Exchange NASDAQ Stock Market
EPS
$0.74
Market Cap
$38.98 M
Shares Outstanding
27.26 M
Public Float
483.54 K

Profile

Address
4170 Mendenhall Oaks Parkway
High Point North Carolina 27265
United States
Employees -
Website http://www.vtvtherapeutics.com
Updated 07/08/2019
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical holding company. The firm engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer.

Financials

View All
Created with Highcharts 5.0.14vTv Therapeutics Inc. Cl ANet Income. Fiscal year is January-December. All values USD Thousands.235 461235 46127 49827 49816 35216 35216 14416 1448 6508 65020142015201620172018050k100k150k200k250k
Created with Highcharts 5.0.14vTv Therapeutics Inc. Cl ASales/Revenue. Fiscal year is January-December. All values USD Thousands.1 5491 54951951963463429129112 43412 4342014201520162017201802.5k5k7.5k10k12.5k15k

Jeff B. Kindler
Executive Chairman
Paul M. Meister
Director